Cargando…

Epigenetic regulation of cathepsin L expression in chronic myeloid leukaemia

The expression and significance of cathepsin L (CTSL) has been extensively studied in solid tumours. However no such information in chronic myeloid leukaemia (CML) was available. We investigated the activity and expression of this protease in peripheral blood mononuclear cells (PBMCs) of 47 adult CM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Samaiya, Misti, Bakhshi, Sameer, Shukla, Abhay A, Kumar, Lalit, Chauhan, Shyam S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2011
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394228/ https://www.ncbi.nlm.nih.gov/pubmed/21496199 http://dx.doi.org/10.1111/j.1582-4934.2010.01203.x

Ejemplares similares

Paediatric chronic myeloid leukaemia: Is it really a different disease?
por: Pushpam, Deepam, et al.
Publicado: (2019)

Diagnostic & prognostic role of microRNAs in paediatric acute myeloid leukaemia
por: Kumar, Sachin, et al.
Publicado: (2016)

High fms-like tyrosine kinase-3 (FLT3) receptor surface expression predicts poor outcome in FLT3 internal tandem duplication (ITD) negative patients in adult acute myeloid leukaemia: a prospective pilot study from India
por: Sharawat, Surender Kumar, et al.
Publicado: (2016)

Nucleophosmin mutation analysis in acute myeloid leukaemia: Immunohistochemistry as a surrogate for molecular techniques
por: Chopra, Anita, et al.
Publicado: (2016)

Down Regulation of a Matrix Degrading Cysteine Protease Cathepsin L, by Acetaldehyde: Role of C/EBPα
por: Mir, Riyaz A., et al.
Publicado: (2011)

Asciminib for chronic myeloid leukaemia
Publicado: (2022)

Acute myeloid leukaemia niche regulates response to L‐asparaginase
por: Kaspers, Gertjan J. L.
Publicado: (2019)

Epigenetic Gene Mutations Impact on Outcome in Acute Myeloid Leukaemia
por: Young, Christine S., et al.
Publicado: (2015)

Chronic myeloid leukaemia with marked thrombocytosis
por: Ooi, Jun, et al.
Publicado: (2020)

CCN3: a key growth regulator in Chronic Myeloid Leukaemia
por: McCallum, Lynn, et al.
Publicado: (2009)

Chronic Myeloid Leukaemia in The 21st Century
por: Frazer, Rachel, et al.
Publicado: (2007)

COVID-19 in persons with chronic myeloid leukaemia
por: Li, Weiming, et al.
Publicado: (2020)

Isolated Ocular Manifestations in Chronic Myeloid Leukaemia
por: Maniam, Anita, et al.
Publicado: (2021)

Two ophthalmic presentations of chronic myeloid leukaemia
por: Kiernan, Miles, et al.
Publicado: (2022)

Differential Regulation of Cathepsin S and Cathepsin L in Interferon γ–treated Macrophages
por: Beers, Courtney, et al.
Publicado: (2003)

The role of BET epigenetic readers in acute myeloid leukaemia and other haematological malignancies
por: Huntly, Brian
Publicado: (2013)

E2F1 and epigenetic modifiers orchestrate breast cancer progression by regulating oxygen-dependent ESRP1 expression
por: Ashok, Cheemala, et al.
Publicado: (2021)

PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervix
por: Mann, Minakshi, et al.
Publicado: (2019)

Correction: PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervix
por: Mann, Minakshi, et al.
Publicado: (2019)

microRNA-21 Expression as Prognostic and Therapeutic Response Marker in Chronic Myeloid Leukaemia Patients
por: Beg Mirza, Masroor Ali, et al.
Publicado: (2019)

Chemotherapy of the Myeloid Leukaemias
por: Stuart, John
Publicado: (1980)

Why are patients with chronic myeloid leukaemia (non-)adherent?
por: Abraham, I, et al.
Publicado: (2012)

The underestimated role of basophils in Ph(+) chronic myeloid leukaemia
por: Valent, Peter, et al.
Publicado: (2018)

Strategies For Targeting Chronic Myeloid Leukaemia Stem Cells
por: Carrà, Giovanna, et al.
Publicado: (2019)

Acute abdomen in a patient with chronic myeloid leukaemia
por: Voppuru, Saiesh Reddy, et al.
Publicado: (2020)

Survival with chronic myeloid leukaemia after failing milestones
por: Lauseker, Michael, et al.
Publicado: (2023)

Targeting cathepsin G in myeloid leukemia
por: Alatrash, Gheath
Publicado: (2013)

Eryptotic Phenotype in Chronic Myeloid Leukemia: Contribution of Neutrophilic Cathepsin G
por: Govekar, Rukmini, et al.
Publicado: (2012)

The matricellular protein CCN3 regulates NOTCH1 signalling in chronic myeloid leukaemia
por: Suresh, Sukanya, et al.
Publicado: (2013)

Epigenetic regulation of HOTAIR in advanced chronic myeloid leukemia
por: Li, Ziye, et al.
Publicado: (2018)

Acute Myeloid Leukaemia in Its Niche: the Bone Marrow Microenvironment in Acute Myeloid Leukaemia
por: Ladikou, E. E., et al.
Publicado: (2020)

B-Cell Lymphopoiesis Is Regulated by Cathepsin L
por: Badano, Maria Noel, et al.
Publicado: (2013)

Managing chronic myeloid leukaemia in the elderly with intermittent imatinib treatment
por: Russo, D, et al.
Publicado: (2015)

Clinical pathway for patients with Chronic Myeloid Leukaemia: The Euriclea Project
por: Botti, Stefano, et al.
Publicado: (2017)

Molecular techniques for the personalised management of patients with chronic myeloid leukaemia
por: Alikian, Mary, et al.
Publicado: (2017)

Prospects for achieving treatment‐free remission in chronic myeloid leukaemia
por: Saglio, Giuseppe, et al.
Publicado: (2020)

Mechanisms of Resistance and Implications for Treatment Strategies in Chronic Myeloid Leukaemia
por: Poudel, Govinda, et al.
Publicado: (2022)

The Spliceosome: A New Therapeutic Target in Chronic Myeloid Leukaemia
por: Lebecque, Benjamin, et al.
Publicado: (2022)

Erythropoiesis in Murine Myeloid Leukaemia
por: Tanaka, T.
Publicado: (1970)

Desacetylmethylcolchicine in the Treatment of Myeloid Leukaemia
por: Jelliffe, A. M., et al.
Publicado: (1956)

Cannot write session to /tmp/vufind_sessions/sess_sjl3gtitli02s4md1nb943oukl